市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 4.8 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
推动市场增长的关键因素是慢性病的高发病率、POC（即时）诊断的使用增加、先进技术、意识的提高以及对个性化药物的接受度。政府医疗保健支出和消费者医疗保健支出的增加也是市场增长的原因。
美国体外诊断市场的增长主要是由于 2020 年心脏病、癌症、哮喘和糖尿病等慢性病以及 COVID -19 的高发病率。据估计，这些疾病占大多数的死亡人数，每年造成超过 170 万公民死亡。因此，IVD 已被证明有利于管理这些慢性病。IVD 有助于检测早期预警信号和个体风险因素，为预防和早期干预创造新机会。
还有新兴的技术创新，例如芯片实验室、可穿戴设备和 POC 诊断，它们正日益成为医疗保健领域的重要组成部分。这些 POC 诊断产品已被开发用于在医院的患者床边获得即时结果，而无需将样本发送到实验室。因此，由于易于使用和提供即时结果的能力，POC 诊断在美国的使用正在迅速增加，从而促进了所研究市场的增长。
报告范围
根据报告的范围，体外诊断是用于对各种生物样本进行体外测试的医疗设备和耗材。它们用于诊断各种医疗状况。这些体外诊断产品可以是用于诊断疾病的仪器、试剂或任何系统。
| By Test Type | |
| Clinical Chemistry | |
| Molecular Diagnostics | |
| Immuno Diagnostics | |
| Haematology | |
| Other Test Types |
| By Product | |
| Instruments | |
| Reagents | |
| Other Products |
| By Usability | |
| Disposable IVD | |
| Reusable IVD |
| By Application | |
| Infectious Diseases | |
| Diabetes | |
| Cancer/Oncology | |
| Cardiology | |
| Autoimmune Diseases | |
| Nephrology | |
| Other Applications |
| By End User | |
| Diagnostic Laboratories | |
| Hospitals and Clinics | |
| Other End Users |
主要市场趋势
癌症/肿瘤学部分预计将在预测期内增长最快
- 由于美国癌症病例的增加，预计肿瘤学将见证最快的复合年增长率。美国对用于治疗慢性病的自我护理设备和 POC 诊断仪的需求也在不断增长，预计这将推动未来市场的增长。根据英国癌症研究中心的数据，2018 年发现了 1700 万例新的癌症病例。这表明全球对基于肿瘤学的诊断测试的需求不断增长。
- 由于肺炎、肺结核和艾滋病毒/艾滋病的高发病率，传染病部分也占有最大的市场份额。因此，随着传染病病例的增加，预计将有助于美国体外诊断市场的增长。
To understand key trends, Download Sample Report
医院和诊所部门预计将在预测期内增长
- 就收入而言，医院和诊所拥有最大的市场份额，这是由于在医院进行的大量诊断测试以及易于用于诊断测试的 II 类和 III 类 IVD 医疗设备的数量不断增加。医院中的医疗保健专业人员利用体外诊断技术进行疾病检测并为每位患者获得最佳结果。
竞争格局
Abbott Laboratories、Becton、Dickinson and Company 和 Danaher Corporation 等公司正在采取战略行动、并购和持续的技术进步，以在未来保持其市场份额。这些公司正专注于提高技术进步，以满足客户的需求，例如提供快速准确结果的全自动系统。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 High Burden of Chronic Diseases
-
4.2.2 Increasing Use of Point-of-care (POC) Diagnostics Spurring the IVD Market
-
4.2.3 Increasing Government Healthcare Expenditure and Consumer's Healthcare Spending
-
4.2.4 Advanced Technologies Fueling the IVD Market
-
4.2.5 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
-
-
4.3 Market Restraints
-
4.3.1 Lack of Proper Reimbursement
-
4.3.2 Stringent Regulatory Framework
-
4.3.3 Need For High Complexity Testing Centers
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Test Type
-
5.1.1 Clinical Chemistry
-
5.1.2 Molecular Diagnostics
-
5.1.3 Immuno Diagnostics
-
5.1.4 Haematology
-
5.1.5 Other Test Types
-
-
5.2 By Product
-
5.2.1 Instruments
-
5.2.2 Reagents
-
5.2.3 Other Products
-
-
5.3 By Usability
-
5.3.1 Disposable IVD
-
5.3.2 Reusable IVD
-
-
5.4 By Application
-
5.4.1 Infectious Diseases
-
5.4.2 Diabetes
-
5.4.3 Cancer/Oncology
-
5.4.4 Cardiology
-
5.4.5 Autoimmune Diseases
-
5.4.6 Nephrology
-
5.4.7 Other Applications
-
-
5.5 By End User
-
5.5.1 Diagnostic Laboratories
-
5.5.2 Hospitals and Clinics
-
5.5.3 Other End Users
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 F Hoffmann-La Roche AG
-
6.1.3 Becton, Dickinson and Company
-
6.1.4 Danaher Corporation
-
6.1.5 bioMerieux SA
-
6.1.6 Bio-Rad Laboratories Inc.
-
6.1.7 Thermo Fisher Scientific Inc.
-
6.1.8 Qiagen
-
6.1.9 Siemens Healthcare GmbH
-
6.1.10 Sysmex Corporation
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The US In Vitro Diagnostics Market market is studied from 2018 - 2026.
What is the growth rate of US In Vitro Diagnostics Market?
The US In Vitro Diagnostics Market is growing at a CAGR of 4.8% over the next 5 years.
Who are the key players in US In Vitro Diagnostics Market?
Abbott Laboratories, Danaher Corporation, bioMerieux SA, F Hoffmann-La Roche AG, Becton, Dickinson and Company are the major companies operating in US In Vitro Diagnostics Market.
